SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-339934
Filing Date
2017-11-13
Accepted
2017-11-13 08:26:55
Documents
9
Period of Report
2017-11-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407565d8k.htm 8-K 24294
2 EX-99.1 d407565dex991.htm EX-99.1 9672
3 EX-99.2 d407565dex992.htm EX-99.2 13915
4 EX-99.3 d407565dex993.htm EX-99.3 16246
5 GRAPHIC g407565001.jpg GRAPHIC 3705
6 GRAPHIC g407565002.jpg GRAPHIC 10470
7 GRAPHIC g407565003.jpg GRAPHIC 12189
8 GRAPHIC g407565dsp1.jpg GRAPHIC 5841
9 GRAPHIC g407565dsp8.jpg GRAPHIC 6191
  Complete submission text file 0001193125-17-339934.txt   118918
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 171193315
SIC: 2836 Biological Products, (No Diagnostic Substances)